NCT

A partnership involving Heidelberg University Hospital, the National Center for Tumor Diseases, and the German Cancer Research Institute is serving patients across Germany.

The tumor cell genome of 250 prostate cancer patients ages 50 and younger will be compared with gene sequences from healthy cells to uncover gene mutations that can cause and promote prostate cancer, and ultimately to create a map of all genetic modifications involving prostate cancer.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.